DefEYE Inc. Launches as Independent Ophthalmics-Focused Company Delivering Innovative Decellularized Human Placenta-Derived Biologics for Eye Care
Emerging from Verséa Health and Backed by Industry Veterans, DefEYE, Inc. setsits sights on enhancing clinical and surgical care across ocular conditions SARASOTA, FL., October 1, 2025 — DefEYE Inc. (DefEYE), a privately held ophthalmic biologicscompany with a portfolio of decellularized biologic solutions, today announced its launch as anindependent company, effective October 1, 2025. The […]